COMPREHENSIVE LIQUID BIOMARKER FOR PREDICTING EARLY RESISTANCE TO ANDROGEN RECEPTOR SIGNALING INHIBITORS IN METASTATIC PROSTATE CANCER.

University Of Wisconsin System, Madison WI

Investigators